Impact of abdominal or pelvic radiotherapy on disease activity in inflammatory bowel disease: a multicentre cohort study from the GETAID.
Broussard D, Rivière P, Bonnet J, Fotsing G, Amiot A, Peyrin-Biroulet L, Rajca S, Buisson A, Gilleta C, Pelletier AL, Serrero M, Bouguen G, Altwegg R, Hebuterne X, Nancey S, Fumery M, Cadiot G, Nahon S, Rahier JF, Gornet JM, Vendrely V, Laharie D; Groupe d’Étude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).
Broussard D, et al. Among authors: vendrely v.
Aliment Pharmacol Ther. 2021 Feb;53(3):400-409. doi: 10.1111/apt.16176. Epub 2020 Nov 26.
Aliment Pharmacol Ther. 2021.
PMID: 33241906